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Session 1: The Social Challenges 
of Stem Cell Research
Chair: 
Claude Huriet, Director, Institut Curie (France) 
 
Speakers:
- Marina Cavazzana-Calvo, Head of the De-
partment of Biotherapy, Hôpital Necker 
(France)
“Stem Cells - from Basic Research to Appli-
cations: the Society Expectations”
- Austin Smith, Director, Wellcome Trust 
Centre for Stem Cell Research, University of 
Cambridge (Great Britain)
“Pluripotent Stem Cells from Embryos and 
Adults”
Discussant: 
- Didier Sicard, Professor, Université René 
Descartes, former President, Comité consul-
tatif national d’éthique (France)
Session 2: Safety and Health Crises
Chair: 
Didier Tabuteau, Director, Chaire Santé, 
Sciences-Po (France)
Speakers:
- Paul Dorfman, Senior Research Fellow at 
the NHS Centre for Involvement, University 
of Warwick (Great Britain)
“Radiation risk, rationality and citizen invol-
vement”
- Michel Setbon, Research Director, CNRS, 
Head of the Centre interdisciplinaire sur le 
risque et sa régulation, Ecole des hautes 
études en santé publique (France)
“Risks and crises in the Nuclear Industry: 
The La Hague model”
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Session 3: The User in the Health 
System
Chair: 
Gilles Duhamel, National Inspector for So-
cial Affairs (France)
Speakers:
- Johan Hjertqvist, President, Health Consu-
mer Powerhouse (Sweden)
“Europe of the Healthcare Consumer”
- Christian Saout, President, Collectif inter-













Health is a very sensitive area in so far as 
it affects everybody intimately. Everybody 
has been, is, or will be faced with health 
issues. Everybody knows somebody close 
to them who is seriously or even fatally ill. 
Society therefore has huge expectations in 
matters of health and hence of medical re-
search. 
Health and associated research are also 
characterized by two aspects – the indivi-
dual and the collective. They are individual 
in so far as medical research impinges on 
our own person, involves trials on human 
beings and, because the patient has by de-
finition a part to play in the treatment ad-
ministered and because they entail a need 
for dialogue between researchers, doctors 
and citizens. They are collective in so far as 
many diseases or health risks have a gene-
ral dimension, involving actions or respon-
ses from public authorities, which in turn 
also require a relationship with the general 
public.
This workshop, which is divided into 
three sessions, enabled us to define a cer-
tain number of specific features peculiar to 
health and medical research and to the dialo-
gue which needs to be established between 
the different parties involved. 
rePort on “the social challenges 
of steM cell research”
This session illustrated an initial element 
specific to medical research, namely that 
it is a scientific area in which knowledge 
is developing very fast, so that very few 
real scientific certainties exist in the most 
cutting-edge fields. The issue therefore arises 
of the appropriation of transient scienti-
fic truths by society. As was highlighted by 
the chair of the session, Professor Claude 
Huriet, there exists simultaneously a very 
strong societal demand on the part of the 
citizen, who has become a consumer in mat-
ters medical, a knowledgeable consumer 
of knowledge and innovation. This places 
great pressure on researchers for results, 
which can lead to a mismatch between ex-
pectations and the real applications of these 
discoveries, as well as to unsatisfactory re-
search conditions (i.e. difficulties obtaining 
funding for research which is not justified by 
therapeutic ends). 
The example of stem cell use was very re-
presentative of the issues as a whole (issues 
of ethical use, medical safety, financial exploi-
tation, etc.) in which the different actors in 
the dialogue are involved. In ethical terms in 
particular, Professor Sicard, former President 
of the National Consultative Committee on 
Ethics emphasized in discussions the utopia 
of ethical regulation of innovations, whilst 
warning of the risk of the orchestration of 
science by ends other than knowledge. 
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Presentations by the two scientific spea-
kers, Dr Marina Cavazzana-Calvo and Pro-
fessor Austin Smith, cast light on the lin-
guistic gap existing between scientists and 
members of the public on such cutting-edge 
topics. However, dialogue is necessary in 
spite of these difficulties because these 
scientific discoveries can lead citizens and 
society to ask themselves more general, 
ethical, economic, social or philosophical 
questions. The scientific community, there-
fore, has a responsibility to initiate this dia-
logue, as was done successfully in the United 
Kingdom, for example, on the issue of stem 
cells, but there is also a need to define a 
common language which is not exclusively 
scientific, possibly requiring intermediaries 
or mediators. 
rePort on “safety and health 
crises”
The second session highlighted the im-
portance of structured dialogue when faced 
with public perception of threat. Whether 
the threat be from infection or, as in the ins-
tances presented in the workshop, nuclear 
power, it can lead to health crises whose 
treatment is made more complex by several 
factors. 
The first of these factors is the difficulty 
experienced by the public in understanding 
the concepts of statistical risk and uncer-
tainty. A health risk can be calculated in the 
majority of cases, but there is often a series 
of biological, epidemiological or other ele-
ments which remains uncertain. The diffi-
culty for public authorities lies in transposing 
these uncertainties into certainties in terms 
of regulations for prevention or cure. These 
uncertainties and the variable perception 
of risk on the part of the public generate 
their own interpretation of scientific data 
and conclusions. In the event of a health 
crisis, there is a juxtaposition between poli-
tical certainties and social uncertainty which 
reinforces the need for open, structured 
dialogue.
A second characteristic feature of safety 
in health is its collective dimension, which 
requires a response in the form of collective 
dialogue. Yet we observe in health matters 
that social debate often, or even only, moves 
forward when there is a crisis. In tandem 
with the hopes raised by medical research 
which create the social pressure described 
above, health is also a cause for anxiety and 
fear. In a sense, crises provide as many op-
portunities as they do risks for science.
The examples given by speakers in the 
course of the session demonstrate the gap 
which often exists in society between per-
ception and reality of health risks (both in 
a positive and in a negative sense) and the 
need for open debate, since failure to do 
this costs society dear. One of the essential 
elements of this debate is for the different 
parties to accept that they do not possess 














tainties and to recognize the possibility of 
being wrong. One interesting lesson to be 
learned from health crises, apart from the 
importance of initiating dialogue early, is 
that the simple fact of engaging in dialogue 
in a spirit of openness can reduce the crisis 
at a social level, even if no final consensus 
is achieved.
 
rePort on “the health systeM 
user”
As was mentioned by Gilles Duhamel in 
his introduction, users are increasingly well-
informed about their diseases and treat-
ments available. They therefore want to be 
involved in the decisions made concerning 
them and to be a stakeholder in a system 
which is still essentially controlled by health 
professionals and public authorities.
For Johan Hjertqvist, there is still a si-
gnificant gap between experts on the one 
hand and patients on the other, in spite of 
the introduction of patients’ rights in many 
European countries. Yet the patient is re-
questing information and knowledge in what 
is increasingly developing into a health ser-
vice marketplace. It is therefore necessary 
to build a bridge between these two worlds, 
as is being attempted by a number of asso-
ciations and organizations. By carrying out 
health service performance measurement 
from outside the system, these organiza-
tions are a positive force for improvement. 
Christian Saout described another ap-
proach, which consisted of taking part in 
dialogue by becoming part of the system 
itself. A slow rise in patient participation in 
the health system can indeed be observed, 
but more often than not this still only ta-
kes place during crises in a reactive rather 
than a preventive manner. Health service 
user bodies have only recently obtained le-
gal status in France (2002) and still encoun-
ter many barriers erected both by health 
professionals and the authorities. Different 
States undoubtedly need more constructive 
dialogue with society if they are to respond 
to the enormous challenges of the ageing 
population, chronic ill-health or lack of re-
sources.
This essential dialogue between health 
system users, professionals and the autho-
rities therefore raises several unknown fac-
tors: for the dialogue to be effective is the 
best place for the patient inside or outside 
the system? How can the risk of health ser-
vice regulators or producers orchestrating 
participants be avoided? How can we make 
available or use the huge amount of infor-
mation stemming from the medical research 
which is developing all the time?
 
In more general terms, we can see that 
dialogue on health issues between scien-
tists, experts, governments, administrative 
authorities and members of the general pu-
blic is still suffering from serious limitations. 
Although this is an area in which public de-
mand for information and involvement is 
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very high, discussions are often limited to 
experts. Unlike other areas such as the en-
vironment or planning, for example, public 
debate on health is still in its infancy and it 
only makes sporadic progress when there is 
a serious crisis. 
What health requires is the growth of me-
chanisms for open, transparent debate, pro-
moting greater involvement on the part of 
society in this crucial area. The rapid growth 
of new technologies which raise social is-
sues (genetic testing, stem cell research, 
etc.), demographic growth and the appea-
rance of new diseases are all subjects on 
which society cannot avoid initiating more 
open dialogue. It is time to put the neces-
sary mechanisms in place to establish this 
dialogue in order to avoid further crises of 
confidence which will be detrimental to all 
concerned. 
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